Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.50
Bid: 21.00
Ask: 22.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.762%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 21.50
TEAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Loreto Ltd]

7 Apr 2021 18:15

RNS Number : 7456U
Team PLC
07 April 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

LORETO LIMITED

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and

beneficiaries must be named.

IMPERIUM TRUST COMPANY LTD AS TRUSTEES OF THE STAR OF THE SEA TRUST SETTLOR - JEAN MARTIN POPIEL BENS - JEAN MARTIN POPIEL & KAREN POPIEL

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TEAM plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/04/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

284,090

1.7

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

284,090

1.7

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a

long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description

e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option

relates

Exercise price per unit

Type

e.g.

American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

(c) Attachments

 

 

 

Date of disclosure:

07/04/2021

Contact name:

Jenny Chester

Telephone number*:

0153 4877 210 (TEAM plc)

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at w ww.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUBABRAOUSRAR
12
Date   Source Headline
28th Mar 20247:02 amRNSWrap Retail Offer
28th Mar 20247:01 amRNSPlacing, Subscription and Wrap Retail Offer
28th Mar 20247:00 amRNSFinal Results
29th Feb 20244:00 pmRNSChange of Adviser
27th Dec 20237:00 amRNSAcquisition of HBFS
12th Dec 20237:00 amRNSAcquisition of Neba Businesses
9th Nov 202312:20 pmRNSHolding(s) in Company
8th Nov 20239:50 amRNSHolding(s) in Company
7th Nov 20234:40 pmRNSHolding(s) in Company
27th Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Sep 20237:00 amRNSLoan Note
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20237:02 amRNSAcquisition
1st Jun 20237:01 amRNSAcquisition
1st Jun 20237:00 amRNSHalf-year Report
31st Jan 20234:00 pmRNSResult of AGM
12th Jan 202311:30 amRNSNotice of AGM
11th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSFinal Results
26th Oct 20222:18 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSChange of Adviser
9th Aug 20224:45 pmRNSDirector/PDMR Shareholding
8th Aug 20229:03 amRNSAcquisition
4th Aug 20223:35 pmRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSCompletion of Acquisition
1st Jul 20221:45 pmRNSDirector/PDMR Shareholding
23rd Jun 20221:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:10 pmRNSResult of AGM
22nd Jun 20227:00 amRNSHalf-year Report
7th Jun 20229:15 amRNSNotice of AGM
16th May 20225:30 pmRNSDirector/PDMR Shareholding
16th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20227:05 amRNSChanges to Management Incentive Plan
12th May 20227:00 amRNSProposed Acquisition, Subscription &Trading Update
23rd Feb 20227:00 amRNSIssue of Equity
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:01 amRNSFinal Results
1st Dec 20217:00 amRNSAcquisition
5th Oct 202110:30 amRNSChange of Registered Office
26th Aug 20211:10 pmRNSDirector/PDMR Shareholding
10th Aug 202110:45 amRNSDirector/PDMR Shareholding
5th Jul 202111:05 amRNSDirector/PDMR Shareholding
5th Jul 20217:00 amRNSAcquisition of JCAP Limited
24th May 20217:00 amRNSDirector Dealing
21st May 20217:00 amRNSInterim Results
20th May 20216:00 pmRNSResult of AGM
29th Apr 20217:00 amRNSNotice of AGM
23rd Apr 20219:45 amRNSForm 8.5 (EPT/RI)
22nd Apr 20218:30 amRNSForm 8.5 (EPT/RI)
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.